| Comment on FDA's Breakthrough Therapy Designation of Intranasal Esketamine for the Treatment of Major Depressive Disorder with Imminent Risk of Suicide | Reji THOMAS, Mesut CETİN, Glen B. BAKER, M. Serdar DURSUN | 329–331 |
| Fractional Anisotropic Changes of Corpus Callosum Associated with Antipsychotic Treatment in First-Episode Antipsychotic Drug-Naive Patients with Schizophrenia | Erdal PAN, Mehmet Alpay ATES, Ayhan ALGUL, Aykut AYTEKİN, Cengiz BASOGLU, Servet EBRİNC, Mesut CETİN, Samet KOSE | 332–341 |
| Agmatine, a metabolite of arginine, improves learning and memory in streptozotocininduced Alzheimer's disease model in rats | Muge SİRVANCİ YALABİK, Ahmet Ozer SEHİRLİ, Tijen UTKAN, Feyza ARİCİOGLU | 342–354 |
| Extensive gray matter volume reduction and correlations with neuropsychological performance in alcohol use disorder patients | Serdar NURMEDOV, Samet KOSE, Onur NOYAN, Baris METİN, Sehadet EKMEN, Cumhur AVCİL | 355–363 |
| The effect of intrauterine antipsychotic drug exposure on learning and memory in adult rats | Cetin Hakan KARADAG, Çağatay OLTULU | 364–373 |
| Is depression a predictive factor for polypharmacy in elderly? | Mehmet YURUYEN, Hakan YAVUZER, Filiz DEMİRDAG, Zehra KARA, Serap YAVUZER, Alper DOVENTAS, Deniz Suna ERDİNCLER, Tanju BEGER, Mahir CENGİZ | 374–381 |
| Psychometric Properties of Turkish versions of the Leyton Obsessional Inventory-Child Version (LOI-CV) and Obsessive Beliefs Questionnaire-Child Version (OBQ-CV) | Omer Faruk DEMİREL, Murat BOYSAN, Muhammed Tayyib KADAK, Mahmut Cem TARAKCİOGLU, Zeynep Seda SERTDURAK | 382–396 |
| Turkish version of Acceptance and Action Questionnaire-II (AAQ-II): A reliability and validity analysis in clinical and non-clinical samples | Fatih YAVUZ, Sevinc ULUSOY, Mehtap ISKİN, Fatma Betul ESEN, Huseyin Sehid BURHAN, Mehmet Emrah KARADERE, Nuran YAVUZ | 397–408 |
| Phantom Limb Pain Treated with Duloxetine: A case series | Ilknur YİLDİRİM, Mihriban DALKIRAN, Abdullah GENC, Besir DİKMEN, Senol TURAN | 409–412 |
| Valproate-induced hyperammonemic encephalopathy in a patient with ischemic stroke | Susan SOLOMON, Ramanathan SİNGARAVELU | 413–416 |
| Eosinophilic Myocarditis in Long Term Use of Antipsychotics: Case Series and Review of the Literature | Hanife Alkurt ALKAN, Sultan PEHLİVAN, Dilhan TURKKAN, Dogus Ozdemir KARA, Ahmet ŞAHPAZ | 417–421 |
| Clozapine and Aripiprazole-Induced Stuttering: A Case Report of Turner Syndrome with Schizophrenia | Hülya ERTEKİN, Yusuf Haydar ERTEKİN, Basak SAHİN, Sinan YAYLA, Ersin TURKYİLMAZ, Medine KARA | 422–425 |
| Topiramate in the Adjunctıve Treatment of Tourette Syndrome: A Case Report | Ozlem ONEN, Handan ERKURAN ÖZEK | 426–428 |
| Neuroinflammation in Schizophrenia: A Critical Review and The Future | Feyza ARİCİOGLU, Ceren Sahin OZKARTAL, Gokhan UNAL, Serdar DURSUN, Mesut CETİN, Norbert MÜLLER | 429–437 |
| Restless Leg Syndrome Associated with Aripiprazole | Birmay CAMN | 438–439 |
| Psychotic Disorder or Complex Partial Seizure Disorder Due to a Sequelae of Herpes Simplex Encephalitis and Coincidental Parasagittal Meningioma | Elif AKCAY, Filiz KARADAG, Tugba TUNC | 439–440 |
| Autoimmune Psychosis: Caveats in the Diagnosis | N.A. UVAIS | 440–441 |
| Acute Urinary Retention Related with Sublingual Buprenorphine Administration | Neslihan ALTUNSOY, Asli Enez DARCİN, Nesrin DİLBAZ | 442–443 |
| Risperidone and Lithium for Pathological Laughing | Musa SAHPOLAT, Ali Kemal DEMİR | 443–444 |